Halozyme Therapeutics shares are trading lower after the company reported mixed Q4 financial results.

Halozyme Therapeutics, Inc. +0.24%

Halozyme Therapeutics, Inc.

HALO

67.47

+0.24%

Halozyme Therapeutics shares are trading lower after the company reported mixed Q4 financial results.